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coronary stent thrombus associated with
myocardial infarction: a case report
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Background: Percutaneous coronary intervention with stenting in patients with coronary atheromatous stenosis carry
an inherent risk of affecting the baroreflex-mediated regulation of hemodynamic alterations, especially for heart rate
and blood pressure. To the best of our knowledge, the vagal baroreflex activation associated with acute coronary stent
thrombosis in patients who have undergone percutaneous coronary intervention has not been previously reported.
Case presentation: In the present article, we report a case of a Chinese patient (a 75-year-old male) with coronary
artery disease who presented with hemodynamic alterations as a complication of vagal baroreflex activation after
implantation of overlapping stents, followed by stent thrombosis associated with myocardial infarction.
Conclusion: The patient’s vagal baroreflex sensitivity increased after the coronary stenting procedure. He was
successfully treated with intra-aortic balloon pump therapy. Because of its rarity, this case is being reported to
emphasize the importance of using intra-aortic balloon pump therapy.
Keywords: Vagal baroreflex activation, Acute coronary stent thrombosis, Myocardial infarctionBackground
Percutaneous coronary intervention (PCI) has become an
important procedure for the treatment of myocardial in-
farction. Although autonomic activity, baroreflex sensitiv-
ity, and hemodynamic alterations resulting from vagal
baroreflex activation (VBA) have been reported in patients
who have undergone carotid angioplasty and stenting
[1-3], there are few data available about the hemodynamic
alterations resulting from VBA in PCI patients [4]. The
present article reports the case of a patient who developed
an acute stent thrombosis associated with myocardial
infarction, which resulted from VBA after PCI. To the best
of our knowledge, the autonomic activity, baroreflex sensi-
tivity, and hemodynamic alterations resulting from VBA
in patients treated with PCI have not been previously
reported.* Correspondence: winterlee@hotmail.com
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A 75-year-old Chinese man who had been experiencing
chest pain for 10 years presented at our institution. He
was moderately active, doing odd jobs around the house,
and accelerating angina over the past 2 years. The patient
had been taking aspirin, nifedipine for high blood pressure
and metformin for diabetes mellitus type 2 for almost
10 years. He smoked one pack of cigarettes per day for
about 40 years before quitting the previous year. His past
history was remarkable for chronic obstructive pulmonary
disease.
At the time of admission, the physical examination
showed heart rate (HR), 67 beats/min (bpm); blood pres-
sure (BP), 156/89 mmHg; and blood glucose, 6.85 mmol/L.
An electrocardiogram (ECG) showed a sinus rhythm with
ST depression and T-wave inversion when chest pain
occurred. A complete blood count and a basal metabolic
profile were examined; the evaluation of kidney function,
blood acid, base balance, and blood sugar levels showed
that there were all within a normal range. The treadmill ex-
ercise test was positive, and showed ST depression on the
ECG when chest pain or shortness of breath occurred. The
patient’s response to clopidogrel therapy was determined by. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Jing et al. BMC Cardiovascular Disorders 2014, 14:131 Page 2 of 5
http://www.biomedcentral.com/1471-2261/14/131testing for CYP450 genetic polymorphism, which showed
non-resistance to such therapy. Testing for CYP450 genetic
polymorphism was to predict response to clopidogrel [5].
The patient was prepared for coronary angiography
(and stent placement if necessary). Before the procedure,
the patient’s spontaneous baroreflex sensitivity (BRS),
heart rate variability (HRV), and blood pressure variability
(BPV) were measured (Table 1). Six hours before the
patient underwent coronary angiography, he was given
300 mg aspirin and 300 mg clopidogrel. An initial dose of
heparin (100U/kg) was intravenously given before the pro-
cedure; an additional dose of heparin at 500U would be
given if the procedure lasted 1 hour. The activated clotting
time was maintained at 325 s.
The coronary angiogram was done through the radial
approach. The angiogramrevealed a proximal 90% diffuse
stenosis with calcification in the middle segment of the left
anterior descending artery (Figure 1A), and 95% stenosis
with calcification in the left circumflex artery (Figure 1B).
The right coronary artery was observed to have >80%
diffuse stenosis with heavy calcification and occlusion in
the middle segment (Figure 1C).
Two overlapping sirolimus-eluting stents (Cypher;
Cordis, Miami, USA.), mounted on a balloon catheter,
were inserted without a gap into the left anterior descend-
ing artery (stents were 36 mm in length and 3 mm in
diameter) and the left circumflex artery (stents 14 mm in
length and 3 mm in diameter), respectively (Figure 2A).
The stents were advanced into the narrowed section of
the arteries. When the stents were positioned, the balloon
was inflated. To ensure full expansion of the stents, the
stent balloon was gradually inflated to 14 atm in 10 to
40 seconds. Because of chronic total occlusion in the right
coronary artery, we attempted to pass a wire through the
lesion but failed. Considering that collateral circulation
was already present, we abandoned the stent placement
into the right coronary artery. After the stenting proced-
ure, the thrombolysis in myocardial infarction (TIMI)
grade was 3, and no cineangiographic characteristics ofTable 1 Heart rate, systolic/diastolic blood pressure, heart
rate variability, blood pressure variability and
spontaneous baroreflex sensitivity before and after
coronary artery stenting
Pre-stenting Post-stenting
HR (beats/min) 67 39
SBP (mmHg) 156 87
DBP (mmHg) 89 52
HRV (ms2) 1019 1728
BPV (mmHg2) 10.1 16.8
BRS (ms/mmHg) 7.2 12.6
BPV: Blood pressure variability; BRS: Spontaneous baroreflex sensitivity; DBP:
Diastolic blood pressure; HR: Heart rate; HRV: Heart rate variability; SBP:
Systolic blood pressure.thrombus were present. The procedure was uneventful
without a special condition for the patient.
Approximately 20 minutes after the procedure (18:40),
the patient developed nausea, vomiting, sweating and slow
breathing associated with diaphoresis and pale complex-
ion. His blood pressure was 87/52 mmHg and heart rate
was 39 bpm. At that time, the patient was conscious and
had no chest pain. No evidence of bleeding or hematoma
was found. The ECG monitor showed no change in ST/T
waves. The HRV and BRS were, however, found to be
greatly elevated (Table 1) compared with the levels mea-
sured before stenting, suggesting VBA. After administra-
tion of 1.5 L intravenous saline with dopamine and
atropine, the BP and HR slightly improved.
However, at 22:50, the patient complained of precor-
dial chest pain and diaphoresis, and presented drowsy,
cold and clammy extremities. His peripheral pulses were
not palpable, and blood pressure was not recordable.
The ECG monitors showed ST elevation in leads V1, V2,
V3 and V4; reciprocal ST depression in leads I, aVL and
aVF; and sinus bradycardia with first-degree heart block.
The cardiac troponin I (cTnI) testing value was 0.06 ng/
mL (normal value 0.04 ng/mL). A diagnosis of myocar-
dial infarction associated with first-degree heart block
and cardiogenic shock was made.
Immediately a repeat coronary angiogram was done
through the femoral approach, and the left anterior de-
scending and circumflex arteries, into which the stents had
been placed, were reexamined. The angiogram revealed
thrombotic occlusion of the planted stents (Figure 2B) in
both the left anterior descending and circumflex arteries,
with TIMI flow grades of 1 and 0, respectively. The
thrombus burden was graded as G3 in the circumflex artery
and as G4 in the left anterior descending artery. No
evidence of artery dissection was found.
An intra-aortic balloon pump (IABP) was immediately
inserted. The TIMI flow grade showed no improvement
after runs of aspiration in the two arteries; at that time
the patient was still in cardiogenic shock. An intracoron-
ary balloon was placed at the location where the thrombi
adhered in the left anterior descending and circumflex
arteries. While continuing counterpulsation of the IABP,
the thrombi in the stents disappeared shortly afterward
(Figure 2C). The patient was given tirofiban, aspirin, clo-
pidogrel and heparin; the balloon counterpulsation was
maintained until the patient’s heart rate normalized and
blood pressure stabilized. The patient was discharged
with a normal echocardiographic evaluation, and was
asymptomatic at follow-up.
Discussion
The hemodynamic alterations involving arterial baroreflex
and cardiac autonomic control in patients undergoing with
carotid angioplasty or stenting are extensively reported
Figure 1 Coronary angiogram showing diffuse stenosis in the middle segments of the left anterior descending artery (A, arrows), the
left circumflex artery (B, arrows) and with occlusion in the right coronary artery (C, arrows).
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undergo PCI with angioplasty and stenting for coronary
stenosis. In this study, we report that VBA caused
hemodynamic alterations after a PCI procedure, followed
by stent thrombosis associated with myocardial infarction.
The patient was successfully treated with intra-aortic
balloon counterpulsation. To the best of our knowledge,
this is the first case describing VBA associated with acute
coronary stent thrombosis after PCI.
In the clinical experience, patients developing VBA with
bradycardia and hypotension during PCI procedure usually
are instantaneous or last for a little while. Interestingly, our
patient developed such hemodynamic alterations 20 mi-
nutes after the procedure. This extremely uncommon inci-
dent raised two questions: 1) whether the vagal stimulation
resulted in the subsequent myocardial infarction or the
myocardial infarction resulted in hemodynamic alterations;
and 2) whether it might just be vice versa and the observed
hemodynamic changes could be the result of a stent
thrombosis.
The patient initially presented nausea, vomiting and slow
breathing associated with diaphoresis and pale complexion,
followed by bradycardia and hypotension. These symptoms
typically result from vagal stimulation. Although occlusionFigure 2 Coronary angiogram showing no stenosis following overlap
anterior descending and circumflex arteries (B, arrows) and thrombusmight also activate cardiac vagal afferents, at that moment
the patient had neither chest pain nor discomfort and
showed no change in ECG. In addition to these clinical fea-
tures, which excluded the possibility of myocardial infarc-
tion, measurements of BRS, HRV and BPV can be used to
evaluate changes in baroreflex control and cardiac auto-
nomic activity [1]. The results showed that the patient’s
BRS level increased, but his HR and BP levels decreased,
suggesting the occurrence of VBA. The baroreflex is a very
important regulatory mechanism for BP and HR [3]. There-
fore, the initial hemodynamic alterations resulted from the
stenting procedure and caused a subsequent stent throm-
bosis associated with myocardial infarction.
The stenting-caused hemodynamic alterations may be
due to the effects of direct artery baroreceptor stimula-
tion. Coronary stenting in patients with coronary ather-
omatous stenosis offers an opportunity to elucidate the
cardiovascular autonomic response to direct intravascu-
lar stimulation of the baroreceptors. VBA development
in patients undergoing coronary stenting could be due
to distension of the coronary artery, which leads to
stimulation of the baroreceptors, an increase in cardiac
parasympathetic stimulation and a decrease in adrener-
gic output to the peripheral vasculature. The continuousping stent implantation (A, arrows), thrombus in the stents in the
disappearing following intra-aortic balloon pump therapy (C).
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creases vagal activity and baroreflex sensitivity. Stress and
pain may also stimulate VBA, which affects hemodynamic
stability and leads to nausea, vomiting, diaphoresis, pale-
ness, decreasing blood pressure and/or drowsiness with
cold and clammy extremities.
Our patient presented a series of clinical features of
VBA resulting from the stenting procedure. The alter-
ations in HR, BP, and breathing components were initially
due to VBA because, at that moment, the patient showed
no evidence of myocardial infarction, except for BRS and
HR/BP levels in opposite manner. With continuing vagal
activity and baroreflex sensitivity, the development of
hemodynamic alterations, including hypotension and de-
creased blood flow in the coronary artery, was subse-
quently complicated by thrombosis in the implanted
stents, as confirmed by the repeat angiogram. As a result
of stent thrombosis or artery occlusion, myocardial infarc-
tion developed as confirmed by ECG and cTnI testing.
In consideration for VBA, it is necessary to exclude the
possibility of cardiac tamponade, especially in a patient who
has undergone PCI with stenting. The examination of BRS
and HRV is a method of identifying patients at risk for car-
diovascular disease associated with autonomic dysfunction
[1]. In our patient, the opposite manner of BRS and HR/BP
levels supported that the hemodynamic alterations resulted
from VBA. Management of the VBA includes the expan-
sion of blood volume and the administration of atropine,
dopamine, and painkillers. These treatments generally
relieve the patient’s symptoms within a short period. How-
ever, our patient had a series of hemodynamic alterations,
followed by thrombosis within the implanted stents. The
thrombi in the stents resulted in myocardial infarction with
cardiogenic shock, which was managed with IABP therapy.
IABP is an important therapy for increasing myocardial
oxygen supply and decreasing myocardial oxygen demand
[6], although its use is at the very least controversial. In
our patient, IABP was used due to the failure of thrombus
aspirations.
The overlapping stents might have contributed to the
risk of thrombosis within the stents, resulting in myocar-
dial infarction. Stenosis of the coronary artery is a main
cause of myocardial infarction [7], because the smallest
minimal luminal diameter is located within the zone of
the stent overlap [8]. Therefore, the initial hemodynamic
alterations caused by VBA were greatly associated with
the subsequent stent thrombosis in our patient.
The mechanism of stent thrombosis is multifactorial
factors [9]. Severe vagal stimulation is an important factor,
which acts to lower heart rate, decrease blood pressure
and slow blood flow, resulting in stent thrombosis or ST-
elevation myocardial infarction. Myocardial reinfarction
caused by stent thrombosis is associated with a larger
thrombus burden [10,11], and stent thrombosis afterprimary PCI may be associated with a particularly poor
prognosis [9]. Dual antiplatelet therapy with aspirin and
clopidogrel is the standard care for most patients under-
going PCI [9]. Regarding clopidogrel therapy, more atten-
tion should be given to the conversion of CYP2C19
enzyme into its active metabolite [9,5].
Conclusion
Coronary stenting caused an increase in baroreflex sensi-
tivity and vagal activation in our patient. The patient’s
condition was complicated by stent thrombosis followed
by myocardial infarction. The patient was successfully
treated with intra-aortic balloon pump therapy. Because
of its rarity, this case is being reported to emphasize the
importance of using intra-aortic balloon pump therapy in
patients such as ours.
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